← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	RCOR 76 DELISTED Renovacor, Inc. RCOR	5	+5	–	$5.38M
77	77 Benitec Biopharma BNTC $295M	4	0	0%	$337K
78	ACHL 78 DELISTED Achilles Therapeutics ACHL	–	–	–	–
79	79 DELISTED Arcellx ACLX	–	–	–	–
80	80 Artiva Biotherapeutics ARTV $296M	–	–	–	–
81	81 BioRestorative Therapies BRTX $2.02M	–	–	–	–
82	82 Candel Therapeutics CADL $682M	–	–	–	–
83	83 Creative Medical Technology CELZ $6.21M	–	–	–	–
84	84 DELISTED CERo Therapeutics CERO	–	–	–	–
85	85 Calidi Biotherapeutics CLDI $2.25M	–	–	–	–
86	86 Coya Therapeutics COYA $102M	–	–	–	–
87	87 Caribou Biosciences CRBU $49.8M	–	–	–	–
88	88 DELISTED CARGO Therapeutics CRGX	–	–	–	–
89	DBTX 89 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	–	–	–	–
90	90 enGene Therapeutics ENGN $115M	–	–	–	–
91	91 Estrella Immunopharma ESLA $23.3M	–	–	–	–
92	92 FibroBiologics FBLG $7.08M	–	–	–	–
93	93 4D Molecular Therapeutics FDMT $711M	–	–	–	–
94	FRLN 94 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
95	95 CytoMed Therapeutics GDTC $10.4M	–	–	–	–
96	96 Genenta Science GNTA $32.3M	–	–	–	–
97	GRCL 97 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
98	GRML 98 Greenland Mines Ltd GRML $92.9M	–	–	–	–
99	99 Fractyl Health GUTS $55.2M	–	–	–	–
100	100 Immix Biopharma IMMX $720M	–	–	–	–